July 2024 - Page 6 of 7 - NetworkNewsWire

MondayJul 08, 2024 9:45 am

SenesTech Inc. (NASDAQ: SNES) Offering a Solution to the World Rodent Problem with its One-Of-A-Kind Fertility Control Technology

SenesTech, a rapidly growing provider of proven rodent fertility control products, is looking to address the growing rodent problem with its unique control solutions These rodent fertility control solutions have been tried and tested out in the field with positive results, with the active ingredient in its flagship product scientifically proven to reduce rodent fertility without the use of poisons and traps Their products are unique in offering a viable and sustainable solution, especially with studies having shown that climate change brings with it longer stretches of warmer weather, hence more time for rodent breeding In the fiscal year 2023,…

MondayJul 08, 2024 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Partnership Extension and Launch of New Hybrid Quantum Solver

D-Wave announced an extension of its partnership with Aramco to address geophysical optimization challenges using D-Wave’s quantum technology Over the past two years, the Aramco Research Center has utilized D-Wave's cutting-edge quantum technologies to solve intricate optimization problems related to seismic imaging D-Wave announced the launch of a new hybrid quantum solver for nonlinear programs, designed to tackle increasingly complex real-world problems at its Qubits 2024 user conference D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, has announced an extension of its partnership with Aramco, a global leader in energy and chemicals, to address geophysical…

FridayJul 05, 2024 10:30 am

DGE 5th Clinical Trials Agreements Conference To Discuss Transparency Among CTA Shareholders

DGE invites leaders, executives and professionals from the biotech, pharma, and medical device sectors, to attend the 5th Clinical Trials Agreements Conference being held August 21-22, 2024, in Philadelphia. The conference focuses on discussions such as accelerating negotiations, AI advancements, fair market value, and building a modern day clinical site budget. The event is hosted by Dynamic Global Events (“DGE”), a global leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the pharma, biotech, medical devices, and all healthcare industries. Clinical Trial Agreements rely on effective communication among sponsors, CROs, and…

FridayJul 05, 2024 9:45 am

Post-Conference Recap of the 4th PRC Performance Optimization Summit

The 4th PRC Performance Optimization Summit, held on June 5-6, 2024, in Philadelphia, gathered industry leaders to discuss optimizing promotional review committees (“PRC”). The summit featured sessions on compliance strategies, incorporating AI in PRC operations, and managing content updates for various digital platforms. Attendees benefited from expert presentations, interactive workshops, and networking opportunities aimed at enhancing PRC effectiveness and teamwork. Key discussions included ensuring compliance, preparing for modular content updates, and shaping review strategies for emerging technologies like virtual reality and mobile applications. The summit provided a comprehensive overview of best practices for promotional review processes, focusing on real-world applications…

FridayJul 05, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome Treatment

Clene revealed new preliminary data on CNM-Au8 for Rett Syndrome treatment at the International Rett Syndrome Foundation 2024 Annual Meeting in Westminster, Colorado The only current FDA-approved drug for Rett Syndrome is trofinetide, approved in 2023 CNM-Au8 treatment showed improvements in mitochondrial respiration deficits in Rett patient-derived astrocytes Clene (NASDAQ: CLNN), along with its subsidiary Clene Nanomedicine Inc., a biopharmaceutical company specializing in mitochondrial health to address neurological diseases like amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently revealed new preliminary data on CNM-Au8 for Rett Syndrome treatment. The data was presented by Dr. Karen Ho, Clene's Vice President…

WednesdayJul 03, 2024 9:45 am

ECGI Holdings Inc. (ECGI) and Pacific Saddlery to Launch New Line of Ready-to-Wear Equestrian Apparel Targeting Burgeoning Market

ECGI Holdings and Pacific Saddlery are gearing up to launch a new line of ready-to-wear equestrian apparel under Pacific Saddlery’s celebrated Allon brand This launch follows the June 13 announcement that ECGI had signed a binding Letter of Intent (“LOI”) to acquire all outstanding shares of Pacific Saddlery The launch is aimed at catering to the growing demand for high-quality equestrian apparel and tapping into the expected growth in the overall global equestrian market Pacific Saddlery is expected to showcase Pacific Saddlery’s Allon collection at the American Equestrian Trade Association (“AETA”) International trade show in August Earlier in June, ECGI…

WednesdayJul 03, 2024 9:00 am

Nightfood Holdings Inc. (NGTF) Eyes Growth Through Robotics and Sleep-Friendly Snacks

Restaurants services are facing growing pressure for efficiency, which can be accomplished by the integration of robotics into daily performance Nightfood Holdings has acquired Future Hospitality Ventures Holdings, an emerging leader in Robots-as-a-Service for restaurants, subsequently appointing Sonny Wang as CEO of NGTF to lead expansion and growth Nightfood Holdings (OTCQB: NGTF), a previously under-the-radar holding company focused on acquisitions in the hospitality, food service, and CPG sectors, has announced a two-pronged strategic move. This initiative targets both the operational efficiency of the hospitality sector and the growing consumer demand for sleep-focused wellness products. While seemingly disparate on the surface,…

TuesdayJul 02, 2024 9:45 am

SOBRsafe Inc. (NASDAQ: SOBR) Secures Two New Agreements to Provide Its Next-Generation Transdermal Alcohol Detection Solutions to Customers in Behavioral Health Segment

SOBRsafe recently signed hardware/software agreements with Lighthouse Recovery Resources and Mountain House Recovery, both operating in the U.S. behavioral health segment The two new agreements bring the number of new accounts secured in 2024 to 20, compared to three accounts booked in all of 2023 The company is targeting the behavioral health and justice segments, which mandate the use of alcohol testing According to SOBRsafe’s CEO, while businesses and services in the behavioral health and justice segments already use different alcohol testing technologies, they are hungry for evolved solutions SOBRsafe offers SOBRcheck(TM) and SOBRsure, designed to instantaneously detect and report…

TuesdayJul 02, 2024 9:00 am

Formal Study on EM Benefits Provides Substance to Promised Potential of SuperCom Ltd.’s (NASDAQ: SPCB) Flagship Electronic Monitoring Technology

SuperCom Ltd. has developed its PureSecurity Suite of products as an end-to-end electronic monitoring (“EM”) solution to meet the needs of correctional facilities and law enforcement agencies, providing them with the tools they need to manage offenders effectively, prevent domestic violence, and ensure public safety A study published earlier this year in the Journal of Public Economics provided a basis for measuring the benefits of EM programs, not only showing reduced recidivism and prison costs, but also increased worker productivity and children’s educational performance The study on Sweden’s nationwide EM alternative for low-level criminal offenses showed the probability of being…

MondayJul 01, 2024 10:30 am

Summit Recap: 8th Digital Strategy & Innovation for Medical Affairs

The 8th Digital Strategy & Innovation for Medical Affairs Summit took place on June 5-6, 2024, in Philadelphia. This event brought together professionals from pharmaceutical, biotechnology, and medical device sectors to explore the latest digital engagement strategies and innovations in medical affairs. Key topics included leveraging AI to improve patient outreach, tracking the patient journey with digital technologies, and developing effective digital engagement strategies. The summit featured expert presentations, panel discussions, and interactive workshops, allowing attendees to gain insights into best practices and emerging trends. Participants had the opportunity to network with industry leaders and peers, fostering collaborations and sharing…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: July 2024